Rosemont Pharmaceuticals Overview

  • Founded
  • 1967
Founded
  • Status
  • Private
  • Employees
  • 200
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 4
  • Investments
  • 1

Rosemont Pharmaceuticals General Information

Description

Manufacturer and supplier of oral liquid formulations of off-patent and solid-dose pharmaceutical products intended for patients with swallowing difficulties. The company provides liquid and solid medications also provides medicines for anesthesia, cardiovascular system, central nervous system, endocrine system, gastrointestinal system, infections, malignant disease and immunosuppression, musculoskeletal and joint disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • Rosemont House, Yorkdale Industrial Park
  • Braithwaite Street
  • Leeds LS11 9XE
  • England, United Kingdom
+44 0113 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rosemont Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rosemont Pharmaceuticals‘s full profile, request access.

Request a free trial

Rosemont Pharmaceuticals Patents

Rosemont Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3883546-A1 Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability Pending 21-Nov-2018 00000000
US-20190209526-A1 Stable atorvastatin suspension composition Abandoned 17-Aug-2016 00000000000
CA-3034027-A1 Stable atorvastatin suspension composition Pending 17-Aug-2016 00000000000
AU-2017312356-A1 Stable atorvastatin suspension composition Abandoned 17-Aug-2016 00000000000
EP-3500309-A1 Stable atorvastatin suspension composition Pending 17-Aug-2016 A61K31/4015

Rosemont Pharmaceuticals Executive Team (6)

Name Title Board Seat Contact Info
Howard Taylor Chief Executive Officer & Board Member
Timothy Busby Chief Financial Officer & Board Member
Sasa Leskovsek Ph.D Chief Scientific Officer
Iain Fawcett Operations Director, Site Leader & Board Member
Eric Vick Chief Commercial Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Rosemont Pharmaceuticals Board Members (3)

Name Representing Role Since
000000 000000 Rosemont Pharmaceuticals Chief Executive Officer & Board Member 000 0000
0000 0000000 Rosemont Pharmaceuticals Operations Director, Site Leader & Board Member 000 0000
0000000 00000 Rosemont Pharmaceuticals Chief Financial Officer & Board Member 000 0000
To view Rosemont Pharmaceuticals’s complete board members history, request access »

Rosemont Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rosemont Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Rosemont Pharmaceuticals‘s full profile, request access.

Request a free trial

Rosemont Pharmaceuticals Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000 25-Nov-2021 0000000000 Buildings and Property 000000 00
To view Rosemont Pharmaceuticals’s complete investments history, request access »